Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
47
CNS Quote, Financials, Valuation and Earnings
Last price:
$75.52
Seasonality move
:
4.01%
Day range:
$74.00 - $76.32
52-week range:
$68.99 - $110.67
Dividend yield:
3.19%
P/E ratio:
24.83x
P/S ratio:
7.09x
P/B ratio:
7.63x
Volume:
283.6K
Avg. volume:
194.7K
1-year change:
-6.23%
Market cap:
$3.9B
Revenue:
$536.8M
EPS (TTM):
$3.06
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $430.9M | $586.7M | $573.7M | $504.3M | $536.8M | |
| Revenue Growth (YoY) | 3.2% | 36.16% | -2.21% | -12.11% | 6.45% | |
| Cost of Revenues | $271.5M | $271.3M | $291.8M | $254.4M | $275.1M | |
| Gross Profit | $159.4M | $315.4M | $282M | $249.9M | $261.6M | |
| Gross Profit Margin | 36.98% | 53.75% | 49.15% | 49.56% | 48.75% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $56.3M | $48M | $54.8M | $66.7M | $60.1M | |
| Other Inc / (Exp) | -$5M | $18.7M | -$25.9M | $1.2M | $17.3M | |
| Operating Expenses | $60.9M | $52.1M | $59.2M | $70.8M | $69.4M | |
| Operating Income | $98.4M | $263.2M | $222.8M | $179.1M | $192.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $93.4M | $281.9M | $196.9M | $180.3M | $209.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $18.2M | $55.8M | $47.4M | $43.6M | $46.7M | |
| Net Income to Company | $75.2M | $226.2M | $149.5M | $136.6M | $162.8M | |
| Minority Interest in Earnings | $1.4M | -$14.8M | $21.6M | -$7.6M | -$11.5M | |
| Net Income to Common Excl Extra Items | $76.6M | $211.4M | $171M | $129M | $151.3M | |
| Basic EPS (Cont. Ops) | $1.60 | $4.38 | $3.51 | $2.62 | $3.00 | |
| Diluted EPS (Cont. Ops) | $1.57 | $4.31 | $3.47 | $2.60 | $2.97 | |
| Weighted Average Basic Share | $47.8M | $48.3M | $48.8M | $49.3M | $50.4M | |
| Weighted Average Diluted Share | $48.7M | $49.1M | $49.3M | $49.6M | $50.9M | |
| EBITDA | $114.7M | $279.3M | $228.4M | $184.2M | $203.4M | |
| EBIT | $98.4M | $263.2M | $222.8M | $179.1M | $192.2M | |
| Revenue (Reported) | $430.9M | $586.7M | $573.7M | $504.3M | $536.8M | |
| Operating Income (Reported) | $98.4M | $263.2M | $222.8M | $179.1M | $192.2M | |
| Operating Income (Adjusted) | $98.4M | $263.2M | $222.8M | $179.1M | $192.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $126.4M | $155.1M | $129.3M | $126.6M | $139.8M | |
| Revenue Growth (YoY) | 18.12% | 22.73% | -16.63% | -2.06% | 10.43% | |
| Cost of Revenues | $62.3M | $88.7M | $63.1M | $65.4M | $69.7M | |
| Gross Profit | $64.1M | $66.4M | $66.2M | $61.2M | $70.1M | |
| Gross Profit Margin | 50.72% | 42.81% | 51.22% | 48.36% | 50.13% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $10.4M | $13.5M | $17.1M | $14.8M | $17.2M | |
| Other Inc / (Exp) | $4.3M | $4.2M | -$1.6M | $1.1M | $2.4M | |
| Operating Expenses | $11.5M | $14.5M | $18.1M | $17M | $19.5M | |
| Operating Income | $52.6M | $51.9M | $48.1M | $44.2M | $50.6M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $56.9M | $56.1M | $46.5M | $45.3M | $53M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $4.5M | $9.3M | $10.2M | $10.9M | $9.7M | |
| Net Income to Company | $52.4M | $46.8M | $36.3M | $34.4M | $43.3M | |
| Minority Interest in Earnings | -$3.6M | -$4.8M | -$984K | -$410K | -$3.5M | |
| Net Income to Common Excl Extra Items | $48.9M | $42M | $35.3M | $34M | $39.8M | |
| Basic EPS (Cont. Ops) | $1.01 | $0.86 | $0.72 | $0.69 | $0.78 | |
| Diluted EPS (Cont. Ops) | $1.00 | $0.85 | $0.71 | $0.68 | $0.77 | |
| Weighted Average Basic Share | $48.1M | $48.7M | $49.2M | $49.6M | $51.1M | |
| Weighted Average Diluted Share | $48.7M | $49.3M | $49.4M | $49.8M | $51.4M | |
| EBITDA | $56.6M | $55.9M | $53.4M | $46.9M | $53.4M | |
| EBIT | $52.6M | $51.9M | $48.1M | $44.2M | $50.6M | |
| Revenue (Reported) | $126.4M | $155.1M | $129.3M | $126.6M | $139.8M | |
| Operating Income (Reported) | $52.6M | $51.9M | $48.1M | $44.2M | $50.6M | |
| Operating Income (Adjusted) | $52.6M | $51.9M | $48.1M | $44.2M | $50.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $450.3M | $615.4M | $547.9M | $501.6M | $550M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $281.1M | $297.8M | $266.1M | $256.7M | $279.5M | |
| Gross Profit | $169.2M | $317.7M | $281.8M | $244.9M | $270.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $43.1M | $51.2M | $58.4M | $64.4M | $62.5M | |
| Other Inc / (Exp) | $20.3M | $18.6M | -$31.7M | $3.9M | $18.6M | |
| Operating Expenses | $47.7M | $55.1M | $62.8M | $69.7M | $71.9M | |
| Operating Income | $121.5M | $262.6M | $219M | $175.2M | $198.6M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $141.8M | $281.2M | $187.3M | $179M | $217.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $22.2M | $60.6M | $48.4M | $44.3M | $45.5M | |
| Net Income to Company | $119.5M | $220.6M | $138.9M | $134.7M | $171.7M | |
| Minority Interest in Earnings | -$14.7M | -$16M | $25.4M | -$7M | -$14.6M | |
| Net Income to Common Excl Extra Items | $104.9M | $204.6M | $164.3M | $127.7M | $157M | |
| Basic EPS (Cont. Ops) | $2.19 | $4.21 | $3.36 | $2.58 | $3.09 | |
| Diluted EPS (Cont. Ops) | $2.16 | $4.15 | $3.33 | $2.57 | $3.06 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $138.2M | $278.6M | $233.6M | $185.5M | $213M | |
| EBIT | $121.5M | $262.6M | $219M | $175.2M | $198.6M | |
| Revenue (Reported) | $450.3M | $615.4M | $547.9M | $501.6M | $550M | |
| Operating Income (Reported) | $121.5M | $262.6M | $219M | $175.2M | $198.6M | |
| Operating Income (Adjusted) | $121.5M | $262.6M | $219M | $175.2M | $198.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $126.4M | $155.1M | $129.3M | $126.6M | $139.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $62.3M | $88.7M | $63.1M | $65.4M | $69.7M | |
| Gross Profit | $64.1M | $66.4M | $66.2M | $61.2M | $70.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $10.4M | $13.5M | $17.1M | $14.8M | $17.2M | |
| Other Inc / (Exp) | $4.3M | $4.2M | -$1.6M | $1.1M | $2.4M | |
| Operating Expenses | $11.5M | $14.5M | $18.1M | $17M | $19.5M | |
| Operating Income | $52.6M | $51.9M | $48.1M | $44.2M | $50.6M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $56.9M | $56.1M | $46.5M | $45.3M | $53M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $4.5M | $9.3M | $10.2M | $10.9M | $9.7M | |
| Net Income to Company | $52.4M | $46.8M | $36.3M | $34.4M | $43.3M | |
| Minority Interest in Earnings | -$3.6M | -$4.8M | -$984K | -$410K | -$3.5M | |
| Net Income to Common Excl Extra Items | $48.9M | $42M | $35.3M | $34M | $39.8M | |
| Basic EPS (Cont. Ops) | $1.01 | $0.86 | $0.72 | $0.69 | $0.78 | |
| Diluted EPS (Cont. Ops) | $1.00 | $0.85 | $0.71 | $0.68 | $0.77 | |
| Weighted Average Basic Share | $48.1M | $48.7M | $49.2M | $49.6M | $51.1M | |
| Weighted Average Diluted Share | $48.7M | $49.3M | $49.4M | $49.8M | $51.4M | |
| EBITDA | $56.6M | $55.9M | $53.4M | $46.9M | $53.4M | |
| EBIT | $52.6M | $51.9M | $48.1M | $44.2M | $50.6M | |
| Revenue (Reported) | $126.4M | $155.1M | $129.3M | $126.6M | $139.8M | |
| Operating Income (Reported) | $52.6M | $51.9M | $48.1M | $44.2M | $50.6M | |
| Operating Income (Adjusted) | $52.6M | $51.9M | $48.1M | $44.2M | $50.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $41.2M | $184.4M | $247.4M | $187.4M | $183M | |
| Short Term Investments | -- | $23.7M | $15.3M | $78M | $127M | |
| Accounts Receivable, Net | $69.7M | $84.1M | $66.7M | $68.9M | $74.4M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $116M | $295.7M | $331.5M | $339M | $385.8M | |
| Property Plant And Equipment | $41.5M | $30.9M | $145.2M | $169.6M | $167.8M | |
| Long-Term Investments | $155M | $130.9M | $157.7M | $181M | $208.4M | |
| Goodwill | $19.2M | $18.4M | $17.8M | $18.1M | $17.5M | |
| Other Intangibles | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | |
| Other Long-Term Assets | $15.4M | $15.4M | $20M | $27.5M | $31.6M | |
| Total Assets | $348.5M | $492.7M | $673.4M | $736.6M | $812.4M | |
| Accounts Payable | $7.7M | $10.2M | $8.4M | $10.1M | $8.5M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $20.9M | $33.7M | $17M | $15.5M | $15.2M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $123.5M | $148.4M | $246.4M | $243.9M | $237.5M | |
| Common Stock | $535K | $543K | $551K | $558K | $575K | |
| Other Common Equity Adj | -$4.1M | -$5.9M | -$10.8M | -$7.7M | -$10M | |
| Common Equity | $174.2M | $255.2M | $337.6M | $381.2M | $511.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $50.7M | $89.1M | $89.4M | $111.4M | $63.2M | |
| Total Equity | $224.9M | $344.3M | $426.9M | $492.6M | $574.9M | |
| Total Liabilities and Equity | $348.5M | $492.7M | $673.4M | $736.6M | $812.4M | |
| Cash and Short Terms | $41.2M | $208.1M | $262.7M | $265.4M | $309.9M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $54.7M | $84.8M | $149.5M | $99.5M | $65.2M | |
| Short Term Investments | -- | -- | $47.1M | $77.9M | $147M | |
| Accounts Receivable, Net | $72M | $89.4M | $76.6M | $75.3M | $79M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $132.8M | $237.3M | $275.5M | $269.9M | $295.1M | |
| Property Plant And Equipment | $38.3M | $28.1M | $144.8M | $169.8M | $165.9M | |
| Long-Term Investments | $128.4M | $284.5M | $164.3M | $195.1M | $326.4M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $11.5M | $13.8M | $19.6M | $26.8M | $28.3M | |
| Total Assets | $333.1M | $583.2M | $623.4M | $680.7M | $834.9M | |
| Accounts Payable | $8.6M | $9.9M | $9.6M | $7.7M | $8.2M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $19.7M | $82.9M | $22.1M | $36.7M | $19.3M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $81.5M | $143.2M | $193.8M | $205.9M | $193.5M | |
| Common Stock | $542K | $550K | $558K | $564K | $582K | |
| Other Common Equity Adj | -$4.7M | -$7.4M | -$9.2M | -$8.7M | -$7.9M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $62.4M | $184.7M | $92.6M | $95.9M | $133.7M | |
| Total Equity | $251.6M | $440M | $429.6M | $474.8M | $641.4M | |
| Total Liabilities and Equity | $333.1M | $583.2M | $623.4M | $680.7M | $834.9M | |
| Cash and Short Terms | $54.7M | $84.8M | $196.6M | $177.4M | $212.2M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $75.2M | $226.2M | $149.5M | $136.6M | $162.8M | |
| Depreciation & Amoritzation | $16.3M | $16.1M | $5.7M | $5.1M | $11.2M | |
| Stock-Based Compensation | $29.3M | $40.5M | $49.4M | $44.5M | $52.3M | |
| Change in Accounts Receivable | -$12.7M | -$14.8M | $14.2M | -$4M | -$28.3M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $89.2M | $242.9M | $61.7M | $172M | $96.7M | |
| Capital Expenditures | $2.5M | $2.7M | $4.2M | $57M | $11.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.8M | $47.6M | -$2.9M | -$114.8M | -$119.7M | |
| Dividends Paid (Ex Special Dividend) | -$122.5M | -$147.6M | -$107.4M | -$112.4M | -$119.2M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$25.9M | -$22.6M | -$26.8M | -$21.5M | -$21.1M | |
| Other Financing Activities | -$1.3M | $23.7M | $142.1M | $13.9M | $88.9M | |
| Cash From Financing | -$148.9M | -$145.4M | $9M | -$119.1M | $18.2M | |
| Beginning Cash (CF) | $101.4M | $41.2M | $185.4M | $248.7M | $189.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$61.5M | $145.1M | $67.8M | -$61.9M | -$4.9M | |
| Ending Cash (CF) | $41.2M | $185.4M | $248.7M | $189.6M | $183.2M | |
| Levered Free Cash Flow | $86.7M | $240.2M | $57.5M | $115M | $85M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $52.4M | $26.1M | $32.5M | $30.1M | -- | |
| Depreciation & Amoritzation | $4M | $4.1M | $5.1M | $6.3M | -- | |
| Stock-Based Compensation | $11.4M | $12.4M | $11.7M | $13.9M | -- | |
| Change in Accounts Receivable | -$9M | $68.7M | $8.9M | $23.7M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $81.1M | $57.7M | $53.7M | $31.4M | -- | |
| Capital Expenditures | $453K | $881K | $15.5M | $4.2M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.1M | -$13.2M | $3.8M | -$74.4M | -- | |
| Dividends Paid (Ex Special Dividend) | -$21.7M | -$26.8M | -$28.1M | -$29.9M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$81K | -$173K | -$187K | -$134K | -- | |
| Other Financing Activities | -$2.1M | $27.1M | -$2.6M | $27M | -- | |
| Cash From Financing | -$23.7M | $445K | -$30.6M | $65.8M | -- | |
| Beginning Cash (CF) | $54.7M | $84.8M | $153.6M | $100.1M | -- | |
| Foreign Exchange Rate Adjustment | $114K | -$3.1M | $635K | -$102K | -- | |
| Additions / Reductions | $56.4M | $44.9M | $26.9M | $22.8M | -- | |
| Ending Cash (CF) | $111.2M | $126.6M | $181.2M | $122.8M | -- | |
| Levered Free Cash Flow | $80.7M | $56.8M | $38.1M | $27.1M | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $119.5M | $220.6M | $138.9M | $134.7M | $171.7M | |
| Depreciation & Amoritzation | $16.7M | $16M | $6.9M | $2.6M | $11.3M | |
| Stock-Based Compensation | $31.7M | $42.9M | $48.3M | $46.8M | $50.7M | |
| Change in Accounts Receivable | -$13.9M | -$76.3M | $73.4M | -$16.8M | -$15.9M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $103.7M | $127.5M | $153.2M | $191.8M | -$17.1M | |
| Capital Expenditures | $2.1M | $2.9M | $8.1M | $56.7M | $8.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $45.4M | -$21.9M | -$7.5M | -$109.1M | -$88.4M | |
| Dividends Paid (Ex Special Dividend) | -$125.6M | -$152.7M | -$108.6M | -$113.6M | -$121.6M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$21.3M | -$26.9M | -$21.7M | -$20.5M | -$27.7M | |
| Other Financing Activities | $6.1M | $106.3M | $53M | -$3.7M | $151.7M | |
| Cash From Financing | -$139.8M | -$72.3M | -$76.2M | -$136.8M | $71.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $9.3M | $33.3M | $69.5M | -$54.1M | -$33.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $101.6M | $124.6M | $145M | $135.1M | -$25.5M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $104.8M | $73M | $68.8M | $64.5M | $43.3M | |
| Depreciation & Amoritzation | $8.1M | $8.1M | $10.3M | $9M | $2.8M | |
| Stock-Based Compensation | $20.8M | $24.1M | $22.4M | $26.9M | $11.4M | |
| Change in Accounts Receivable | -$13.3M | $2.9M | $2.4M | $4.4M | -$6.9M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $90M | -$48.8M | $38.7M | $36.2M | -$108.9M | |
| Capital Expenditures | $884K | $1.6M | $20.1M | $8.6M | $1.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $38.1M | -$43.6M | -$31.2M | -$103.7M | $2M | |
| Dividends Paid (Ex Special Dividend) | -$43.5M | -$53.7M | -$56.2M | -$59.2M | -$31.7M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$21.3M | -$25.8M | -$20.6M | -$19.5M | -$26M | |
| Other Financing Activities | $6M | $117.8M | -$948K | $11.1M | $46.8M | |
| Cash From Financing | -$58.2M | $39.1M | -$77.1M | $1.5M | -$10.5M | |
| Beginning Cash (CF) | $95.9M | $269.2M | $402.3M | $289.7M | $183.2M | |
| Foreign Exchange Rate Adjustment | -$19K | -$4.5M | $2M | -$810K | $471K | |
| Additions / Reductions | $70M | -$53.3M | -$69.6M | -$66M | -$117.5M | |
| Ending Cash (CF) | $165.9M | $211.4M | $334.8M | $222.9M | $66.1M | |
| Levered Free Cash Flow | $89.1M | -$50.3M | $18.6M | $27.7M | -$110M | |
Get CNS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CNS
Sector
P/E ratio
24.83x
12.18x
PEG ratio
1.30x
0.40x
P/B ratio
7.63x
1.10x
Price / LTM sales
7.09x
2.66x
Growth Metrics
CNS
Sector
Revenue growth
10.43%
5.1%
Earnings growth
13.24%
2.61%
Revenue (5-year growth)
5.15%
5.17%
Earnings forecast
$0.76
$0.61
Profitability
CNS
Sector
Profitability FY 2024
$261.6M
$138.7M
Return on invested capital
28.16%
5.2%
Return on assets
20.45%
0.97%
Return on equity
28.16%
9.24%
Earnings Date
Last Earnings Date
Jul
17
Next Earnings Date
Jul
17
Estimated Next Earnings Date
Oct
16
Balance Sheet
CNS
Sector
Total cash
$212.2M
$452M
Short term investments
$127M
$220.9M
Total assets
$812.4M
$3.8B
Long term debt
--
$280.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
